Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
Zahra Sahraei, Minoosh Shabani, Shervin Shokouhi, Ali Saffaei
International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2020.105945
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre -including this research content -immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
Declarations Funding: None. Competing Interests: None declared. Ethical Approval: Not required.
References
Gao, Tian, Yang, Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies, Biosci Trends,
doi:10.5582/bst.2020.01047Jorge, Melles, Zhang, Lu, Rai et al., Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines, Arthritis Res Ther,
doi:10.1186/s13075-018-1634-8Lim, Im, Cho, Bae, Klein et al., Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax, Antimicrob Agents Chemother,
doi:10.1128/AAC.00339-08Plantone, Koudriavtseva, Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic, and neurological diseases: a mini-review, Clin Drug Investig,
doi:10.1007/s40261-018-0656-yRainsford, Parke, Clifford-Rashotte, Kean, Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases, Inflammopharmacology,
doi:10.1007/s10787-015-0239-ySavarino, Boelaert, Cassone, Majori, Cauda, Effects of chloroquine on viral infections: an old drug against today's diseases?, Lancet Infect Dis,
doi:10.1016/s1473-3099(03)00806-5DOI record:
{
"DOI": "10.1016/j.ijantimicag.2020.105945",
"ISSN": [
"0924-8579"
],
"URL": "http://dx.doi.org/10.1016/j.ijantimicag.2020.105945",
"alternative-id": [
"S0924857920300959"
],
"article-number": "105945",
"assertion": [
{
"label": "This article is maintained by",
"name": "publisher",
"value": "Elsevier"
},
{
"label": "Article Title",
"name": "articletitle",
"value": "Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine"
},
{
"label": "Journal Title",
"name": "journaltitle",
"value": "International Journal of Antimicrobial Agents"
},
{
"label": "CrossRef DOI link to publisher maintained version",
"name": "articlelink",
"value": "https://doi.org/10.1016/j.ijantimicag.2020.105945"
},
{
"label": "Content Type",
"name": "content_type",
"value": "article"
},
{
"label": "Copyright",
"name": "copyright",
"value": "© 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved."
}
],
"author": [
{
"affiliation": [],
"family": "Sahraei",
"given": "Zahra",
"sequence": "first"
},
{
"affiliation": [],
"family": "Shabani",
"given": "Minoosh",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Shokouhi",
"given": "Shervin",
"sequence": "additional"
},
{
"ORCID": "http://orcid.org/0000-0002-9563-924X",
"affiliation": [],
"authenticated-orcid": false,
"family": "Saffaei",
"given": "Ali",
"sequence": "additional"
}
],
"container-title": "International Journal of Antimicrobial Agents",
"container-title-short": "International Journal of Antimicrobial Agents",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"clinicalkey.jp",
"clinicalkey.com",
"clinicalkey.es",
"clinicalkey.com.au",
"clinicalkey.fr",
"elsevier.com",
"sciencedirect.com"
]
},
"created": {
"date-parts": [
[
2020,
3,
17
]
],
"date-time": "2020-03-17T11:08:36Z",
"timestamp": 1584443316000
},
"deposited": {
"date-parts": [
[
2020,
7,
9
]
],
"date-time": "2020-07-09T22:39:29Z",
"timestamp": 1594334369000
},
"indexed": {
"date-parts": [
[
2024,
5,
13
]
],
"date-time": "2024-05-13T12:40:20Z",
"timestamp": 1715604020047
},
"is-referenced-by-count": 158,
"issue": "4",
"issued": {
"date-parts": [
[
2020,
4
]
]
},
"journal-issue": {
"issue": "4",
"published-print": {
"date-parts": [
[
2020,
4
]
]
}
},
"language": "en",
"license": [
{
"URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2020,
4,
1
]
],
"date-time": "2020-04-01T00:00:00Z",
"timestamp": 1585699200000
}
}
],
"link": [
{
"URL": "https://api.elsevier.com/content/article/PII:S0924857920300959?httpAccept=text/xml",
"content-type": "text/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://api.elsevier.com/content/article/PII:S0924857920300959?httpAccept=text/plain",
"content-type": "text/plain",
"content-version": "vor",
"intended-application": "text-mining"
}
],
"member": "78",
"original-title": [],
"page": "105945",
"prefix": "10.1016",
"published": {
"date-parts": [
[
2020,
4
]
]
},
"published-print": {
"date-parts": [
[
2020,
4
]
]
},
"publisher": "Elsevier BV",
"reference": [
{
"DOI": "10.1016/S1473-3099(20)30119-5",
"article-title": "Open access epidemiological data from the COVID-19 outbreak",
"author": "Xu",
"doi-asserted-by": "crossref",
"journal-title": "Lancet Infect Dis",
"key": "10.1016/j.ijantimicag.2020.105945_bib0001",
"year": "2020"
},
{
"DOI": "10.1016/j.ijantimicag.2020.105923",
"article-title": "Chloroquine for the 2019 novel coronavirus SARS-CoV-2",
"author": "Colson",
"doi-asserted-by": "crossref",
"journal-title": "Int J Antimicrob Agents",
"key": "10.1016/j.ijantimicag.2020.105945_bib0002",
"year": "2020"
},
{
"DOI": "10.5582/bst.2020.01047",
"article-title": "Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies",
"author": "Gao",
"doi-asserted-by": "crossref",
"journal-title": "Biosci Trends",
"key": "10.1016/j.ijantimicag.2020.105945_bib0003",
"year": "2020"
},
{
"DOI": "10.1007/s10787-015-0239-y",
"article-title": "Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases",
"author": "Rainsford",
"doi-asserted-by": "crossref",
"first-page": "231",
"journal-title": "Inflammopharmacology",
"key": "10.1016/j.ijantimicag.2020.105945_bib0004",
"volume": "23",
"year": "2015"
},
{
"DOI": "10.1016/S1473-3099(03)00806-5",
"article-title": "Effects of chloroquine on viral infections: an old drug against today's diseases?",
"author": "Savarino",
"doi-asserted-by": "crossref",
"first-page": "722",
"journal-title": "Lancet Infect Dis",
"key": "10.1016/j.ijantimicag.2020.105945_bib0005",
"volume": "3",
"year": "2003"
},
{
"DOI": "10.1007/s40261-018-0656-y",
"article-title": "Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic, and neurological diseases: a mini-review",
"author": "Plantone",
"doi-asserted-by": "crossref",
"first-page": "653",
"journal-title": "Clin Drug Investig",
"key": "10.1016/j.ijantimicag.2020.105945_bib0006",
"volume": "38",
"year": "2018"
},
{
"DOI": "10.1128/AAC.00339-08",
"article-title": "Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax",
"author": "Lim",
"doi-asserted-by": "crossref",
"first-page": "1468",
"journal-title": "Antimicrob Agents Chemother",
"key": "10.1016/j.ijantimicag.2020.105945_bib0007",
"volume": "53",
"year": "2009"
},
{
"DOI": "10.1186/s13075-018-1634-8",
"article-title": "Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines",
"author": "Jorge",
"doi-asserted-by": "crossref",
"first-page": "133",
"journal-title": "Arthritis Res Ther",
"key": "10.1016/j.ijantimicag.2020.105945_bib0008",
"volume": "20",
"year": "2018"
},
{
"DOI": "10.1016/j.antiviral.2017.11.017",
"article-title": "An evaluation of chloroquine as a broad-acting antiviral against hand, foot and mouth disease",
"author": "Tan",
"doi-asserted-by": "crossref",
"first-page": "143",
"journal-title": "Antiviral Res",
"key": "10.1016/j.ijantimicag.2020.105945_bib0009",
"volume": "149",
"year": "2018"
}
],
"reference-count": 9,
"references-count": 9,
"relation": {},
"resource": {
"primary": {
"URL": "https://linkinghub.elsevier.com/retrieve/pii/S0924857920300959"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine",
"type": "journal-article",
"update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy",
"volume": "55"
}
